Analysts have recently evaluated Myriad Genetics and provided 12-month price targets. The average target is $17.1, ...

A federal judge in Texas has blocked the FDA’s plans to bring laboratory-developed tests under the same regulations it uses ...

Colorectal cancer is a serious but preventable disease if detected early. Advances in diagnostics, such as biomarker analysis ...

The below brands have announced their latest funding rounds, securing fresh capital to drive expansion and innovation.

Synlab is a medical diagnostic services and specialty testing provider. Cinven portfolio company Synlab has completed the sale of its clinical diagnostics operations in Spain to Eurofins Scientific.

Tvaster Genkalp secured $1.25 million in pre-series A funding led by Ideaspring Capital to expand Episcreen Liver, a non-invasive liquid biopsy for early liver cancer detection with 90% sensitivity.

The global bacterial diagnostics in aquaculture market expanded at a CAGR of 4.6% between 2018 and 2022. Based on aquatic animals, carp estimated a market share of 21.4% in 2022. Based on technique, ...

Proving causation is a challenge in healthcare, legal cases, and scientific research. How can professionals confirm that an ...

Researchers from the Faculty of Physics and the Life Sciences Center of Vilnius University (VU), with co-authors from Harvard ...

Learn more about whether PROCEPT BioRobotics Corporation or QuidelOrtho Corporation is a better investment based on AAII's A+ ...